跳至主要内容
临床试验/NCT02694835
NCT02694835已完成不适用

Initial Performance of a Modified Daily Disposable Silicone Hydrogel Contact Lens

Alcon Research0 个研究点目标入组 81 人开始时间: 2016年3月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
81
主要终点
Incidence (Number) of Ocular Discomfort Device-related Adverse Events (AEs)

研究概览

简要总结

The purpose of this study is to evaluate the incidence of ocular discomfort device-related adverse events with DAILIES TOTAL1® with UV Absorber (DT1 UV) contact lenses compared with current DAILIES TOTAL1® (DT1) contact lenses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must sign an Informed Consent document;
  • Current wearers of commercial DT1 lenses (for at least 3 months), with a minimum wearing time of 5 days per week and 8 hours per day;
  • Spherical contact lens correction within the range of -2.00 to -4.00 Diopter (D) in both eyes;
  • Manifest astigmatism less than or equal to 0.75 D (at screening);
  • Best-corrected visual acuity (BCVA) greater than or equal to 20/25 in each eye (as determined by manifest refraction at screening);
  • Other protocol-specified inclusion criteria may apply.

排除标准

  • Eye injury in either eye within 12 weeks prior to study enrollment;
  • Any anterior segment infection, inflammation, disease, or abnormality that contraindicates contact lens wear as determined by the Investigator;
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated, including topical ocular medications and lubrication drops that would require instillation during contact lens wear;
  • History of herpetic keratitis;
  • History of refractive surgery or irregular cornea;
  • Pathologically dry eye that precludes contact lens wear;
  • Concurrent participation (or within the previous 30 days) in a contact lens or lens care product clinical trial;
  • Monocular (only 1 eye with functional vision);
  • Other protocol-specified exclusion criteria may apply.

研究组 & 干预措施

DT1 UV

Experimental

Delefilcon A contact lenses with Ultraviolet (UV) Absorber worn bilaterally (in both eyes) for 9 hours

干预措施: Delefilcon A contact lenses with UV Absorber (Device)

DT1

Active Comparator

Delefilcon A contact lenses worn bilaterally for 9 hours

干预措施: Delefilcon A contact lenses (Device)

结局指标

主要结局

Incidence (Number) of Ocular Discomfort Device-related Adverse Events (AEs)

时间窗: Day 1 at Hour 9 ± 3 hours

An AE was defined as any untoward medical occurrence in a subject who is administered a study treatment regardless of whether or not the event has a causal relationship with the treatment. Reported in units of eyes.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Initial Performance of a Modified Daily Disposable... | 临床试验